As has already been demonstrated by recent insulin price drops, the solution to this problem is more choice and more competition. Our lawmakers should be focused on how to make those things happen, not dictating arbitrary price levels.
A collection of insulin vials. Insulin is an enzymatic injection that Type 1 and some Type 2 diabetics require on a daily basis to live. Between 1996-2018, insulin prices rose by 1,200%, while production costs remained static, according to a study by the Harvard Medical Review. The same study noted prices doubled between 2012 and 2016 alone. Gabriel Lagarde / Brainerd Dispatch file photo